Site Search
Professionals 838 results
Capabilities 83 results
Practice Area
Today’s legal and regulatory landscape is more fraught with risk than ever before. To survive—and thrive—in this challenging environment, sophisticated companies must have robust, proactive, and effective compliance programs in place.
Practice Area
Government Program Fraud, False Claims Act & Qui Tam Litigation
Investigations and litigation involving alleged fraud against the government pose a significant and growing threat to organizations and individuals across all industries that engage directly or indirectly in business with federal, state, and/or local governments. The government makes aggressive use of its extensive criminal and civil investigatory powers to root out alleged fraud and abuse implicating government funds, including one of its most powerful civil enforcement tools—the federal False Claims Act (FCA)—and similar state false claims statutes.
Industry
Winston has one of the world’s premier sports law practices. Our work has included some of the most famous legal matters in sports history—including Alston v. NCAA, the case that culminated in a 9–0 Supreme Court victory for the college players against the NCAA; the US$2.15B Los Angeles Dodgers acquisition; McNeil v. the NFL, the landmark antitrust jury trial that led to the establishment of free agency in the NFL; the multi-billion-dollar construction and permanent financings for SoFi Stadium; and Morgan v. USSF, the case that led to a historic equal pay settlement for the players on the Women’s National Team. Our work is transforming this global, multibillion-dollar industry.
Experience 51 results
Experience
|June 3, 2024
Wells Fargo $1.1 Billion Credit Facility to White Oak ABL 3, LLC
Experience
|May 2, 2024
Winston Represented Amylu Foods in its Acquisition of Klement’s Sausage Company
Insights & News 3,349 results
Speaking Engagement
|October 17, 2024
Claire Fundakowski Presents at 2024 Hatch-Waxman and BPCIA Passport to Proficiency Series
Winston & Strawn partner Claire Fundakowski will present during ACI’s Fourth Annual Passport to Proficiency on the Essentials of Hatch-Waxman and BPCIA.
Seminar/CLE
|September 26, 2024
Public Company Priorities Breakfast or Lunch Program
Join us for Winston & Strawn’s Public Company Advisory series, where our seasoned attorneys will delve into the latest hot topics affecting Public Companies.
Sponsorship
|September 26, 2024
Winston Sponsors MENTOR Newark’s Annual Fundraiser
Winston is a proud sponsor of MENTOR Newark’s annual fundraiser, Welcome to the Yard, a Celebration of Historically Black Colleges & Universities.
Other Results 74 results
Site Content
Law Glossary
What Exclusivity Periods Are Associated with Biosimilars?
An applicant may not submit an aBLA until four years after the reference product is licensed by the FDA. (See BPCIA § 351(k).) Further, any biosimilar licenses “may not be made effective” until 12 years after the reference product was licensed. (See BPCIA § 351(l).)